hematoporphyrin has been researched along with technetium in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anghileri, LJ; Crone-Escanye, MC; Robert, J | 1 |
Babbar, AK; Chauhan, UP; Goel, HC; Sharma, RK; Singh, AK | 2 |
Gupta, S; Jain, V; Mishra, AK; Muralidhar, K | 1 |
4 other study(ies) available for hematoporphyrin and technetium
Article | Year |
---|---|
Enhancement of hematoporphyrin derivative uptake in vitro and in vivo by tumor cells in the presence of lanthanum.
Topics: Animals; Carcinoma, Ehrlich Tumor; Drug Interactions; Hematoporphyrin Derivative; Hematoporphyrins; In Vitro Techniques; Lanthanum; Liver; Metalloporphyrins; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Organotechnetium Compounds; Radiation-Sensitizing Agents; Rhabdomyosarcoma; Technetium | 1985 |
Evaluation of (99m)Tc-labeled photosan-3, a hematoporphyrin derivative, as a potential radiopharmaceutical for tumor scintigraphy.
Topics: Animals; Arboviruses; Drug Stability; Hematoporphyrins; Isotope Labeling; Neoplasms, Experimental; Photosensitizing Agents; Protein Binding; Rabbits; Radionuclide Imaging; Radiopharmaceuticals; Technetium; Tissue Distribution | 2000 |
Evaluation of (99m)Tc-labeled photosan-3, a hematoporphyrin derivative, as a potential radiopharmaceutical for tumor scintigraphy.
Topics: Animals; Carcinoma, Ehrlich Tumor; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Stability; Hematoporphyrins; Metabolic Clearance Rate; Mice; Neoplasm Transplantation; Organ Specificity; Photosensitizing Agents; Rabbits; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sodium Pertechnetate Tc 99m; Technetium; Tin Compounds; Tissue Distribution | 2000 |
Improved targeting of photosensitizers by intratumoral administration of immunoconjugates.
Topics: Animals; Antibodies, Monoclonal; Carcinoembryonic Antigen; Carcinoma, Ehrlich Tumor; Hematoporphyrins; Immunoconjugates; Injections, Intravenous; Liver; Mice; Photochemotherapy; Photosensitizing Agents; Radiotherapy; Technetium; Tissue Distribution | 2004 |